Page last updated: 2024-08-23

diltiazem and isofagomine

diltiazem has been researched along with isofagomine in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Benjamin, ER; Boyd, RE; Khanna, R; Lee, G; Rybczynski, P; Valenzano, KJ; Wustman, BA	1
Mahuran, D; Rigat, B	1

Reviews

1 review(s) available for diltiazem and isofagomine

Article	Year
Pharmacological chaperones as therapeutics for lysosomal storage diseases. Journal of medicinal chemistry, 2013, Apr-11, Volume: 56, Issue:7 Topics: Cell Line; Glycolipids; Humans; Lysosomal Storage Diseases; Molecular Chaperones; Structure-Activity Relationship	2013

Other Studies

1 other study(ies) available for diltiazem and isofagomine

Article	Year
Diltiazem, a L-type Ca(2+) channel blocker, also acts as a pharmacological chaperone in Gaucher patient cells. Molecular genetics and metabolism, 2009, Volume: 96, Issue:4 Topics: Calcium Channel Blockers; Calcium Channels, L-Type; Cell Line; Diltiazem; Dose-Response Relationship, Drug; Enzyme Activation; Fibroblasts; Gaucher Disease; Glucosylceramidase; Hot Temperature; Humans; Hydrogen-Ion Concentration; Imino Pyranoses; Lysosomes; Phenotype; Verapamil	2009

Article

Year

Diltiazem, a L-type Ca(2+) channel blocker, also acts as a pharmacological chaperone in Gaucher patient cells.

Molecular genetics and metabolism, 2009, Volume: 96, Issue:4

Topics: Calcium Channel Blockers; Calcium Channels, L-Type; Cell Line; Diltiazem; Dose-Response Relationship, Drug; Enzyme Activation; Fibroblasts; Gaucher Disease; Glucosylceramidase; Hot Temperature; Humans; Hydrogen-Ion Concentration; Imino Pyranoses; Lysosomes; Phenotype; Verapamil

2009